Good Fortunes shower on Sun Pharma

Launch of Ezallor Sprinkle capsules in US

Shares of Sun Pharma outperform market

New Delhi, July 15(HS) Sun Pharma launched drug in form of capsules called Ezallor Sprinkle for treating lipid related swallowing difficulties. These capsules are available 5 mg, 10 mg, 20 mg and 40 mg dosages. The company is consistently working on its commitment to provide alternative formulation products in US market.

Shares of Sun Pharma have rose by 16 percent including Monday’s more than 3 percent rise outperforming the declining share market indices over last five days. Sensex has risen 31 percent while this stock has risen 41 percent in over two years. It also noticed 1.5 times increase in trade volumes of the scrip. This rise has been driven by expansion of product base, upside estimates of revenue by 13 percent and profit by 20 percent, manufacturing rationalisation controlling costs, its Halol plant contribution, potential resolution of regulatory matters and other catalysts like approvals for various medicines from US and recovery in healthcare industry .